Aurintricarboxylic acid inhibits influenza virus neuraminidase

被引:95
作者
Hung, Hui-Chen [1 ]
Tseng, Ching-Ping [1 ]
Yang, Jinn-Moon [2 ]
Ju, Yi-Wei [1 ]
Tseng, Sung-Nain [3 ]
Chen, Yen-Fu [2 ]
Chao, Yu-Sheng [4 ]
Hsieh, Hsing-Pang [4 ]
Shih, Shin-Ru [3 ,5 ]
Hsu, John T. -A. [1 ,4 ]
机构
[1] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan
[2] Natl Chiao Tung Univ, Inst Bioinformat, Hsinchu, Taiwan
[3] Chang Gung Univ, Dept Med Biotechnol, Tao Yuan, Taiwan
[4] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Miaoli, Taiwan
[5] Chang Gung Mem Hosp, Clin Virol Lab, Tao Yuan, Taiwan
关键词
Aurintricarboxylic acid; Influenza; Neuraminidase; Antivirals; ANTI-HIV ACTIVITIES; IN-VITRO; OSELTAMIVIR CARBOXYLATE; PARAINFLUENZA VIRUS; STRUCTURAL-ANALYSIS; POTENT INHIBITOR; RESISTANT; REPLICATION; DESIGN; TARGET;
D O I
10.1016/j.antiviral.2008.10.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There is a continuing threat that the highly pathogenic avian influenza virus will cause future influenza pandemics. In this study, we screened a library of compounds that are biologically active and structurally diverse for inhibitory activity against influenza neuraminidase (NA). We found that aurintricarboxylic acid (ATA) is a potent inhibitor of NA activity of both group-1 and group-2 influenza viruses with IC50S (effective concentration to inhibit NA activity by 50%) values at low micromolar concentrations. ATA was equally potent in inhibiting the NA activity derived from wild-type NA and its H274Y mutant which renders NA resistance to inhibition by oseltamivir. Although ATA is structurally distinct from sialic acid, molecular modeling experiments suggested that ATA binds to NA at the enzyme's substrate binding site. These results indicate that ATA may be a good starting material for the design of a novel class of NA inhibitors for the treatment influenza viruses. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 63 条
[21]   Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid [J].
He, RT ;
Adonov, A ;
Traykova-Adonova, M ;
Cao, JX ;
Cutts, T ;
Grudesky, E ;
Deschambaul, Y ;
Berry, J ;
Drebot, M ;
Li, XG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (04) :1199-1203
[22]   Development and validation of a genetic algorithm for flexible docking [J].
Jones, G ;
Willett, P ;
Glen, RC ;
Leach, AR ;
Taylor, R .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (03) :727-748
[23]   In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication [J].
Kati, WM ;
Montgomery, D ;
Carrick, R ;
Gubareva, L ;
Maring, C ;
McDaniel, K ;
Steffy, K ;
Molla, A ;
Hayden, F ;
Kempf, D ;
Kohlbrenner, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) :1014-1021
[24]   Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: Design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity [J].
Kim, CU ;
Lew, W ;
Williams, MA ;
Liu, HT ;
Zhang, LJ ;
Swaminathan, S ;
Bischofberger, N ;
Chen, MS ;
Mendel, DB ;
Tai, CY ;
Laver, WG ;
Stevens, RC .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (04) :681-690
[25]  
Klenk H D, 1988, Adv Virus Res, V34, P247, DOI 10.1016/S0065-3527(08)60520-5
[26]   Optimization of small molecule drugs binding to highly polar target sites: Lessons from the discovery and development of neuraminidase inhibitors [J].
Klumpp, Klaus ;
Graves, Bradford J. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (05) :423-434
[27]   Target specific virtual screening: Optimization of an estrogen receptor screening platform [J].
Knox, Andrew J. S. ;
Meegan, Mary J. ;
Sobolev, Vladimir ;
Frost, Dermot ;
Zisterer, Daniela M. ;
Williams, D. Clive ;
Lloyd, David G. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (22) :5301-5310
[28]   Avian flu - Isolation of drug-resistant H5N1 virus [J].
Le, QM ;
Kiso, M ;
Someya, K ;
Sakai, YT ;
Nguyen, TH ;
Nguyen, KHL ;
Pham, ND ;
Ngyen, HH ;
Yamada, S ;
Muramoto, Y ;
Horimoto, T ;
Takada, A ;
Goto, H ;
Suzuki, T ;
Suzuki, Y ;
Kawaoka, Y .
NATURE, 2005, 437 (7062) :1108-1108
[29]   Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071 [J].
Li, WX ;
Escarpe, PA ;
Eisenberg, EJ ;
Cundy, KC ;
Sweet, C ;
Jakeman, KJ ;
Merson, J ;
Lew, W ;
Williams, M ;
Zhang, LJ ;
Kim, CU ;
Bischofberger, N ;
Chen, MS ;
Mendel, DB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :647-653
[30]   TRIPHENYLMETHANE DYES AS INHIBITORS OF REVERSE-TRANSCRIPTASE, RIBONUCLEIC-ACID POLYMERASE, AND PROTEIN-SYNTHESIS - STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
LIAO, LL ;
HORWITZ, SB ;
HUANG, MT ;
GROLLMAN, AP ;
STEWARD, D ;
MARTIN, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (01) :117-120